Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
213 studies found for:    RETINAL VEIN OCCLUSION
Show Display Options
Rank Status Study
1 Recruiting OCT in Retinal Vein Occlusions
Condition: Retinal Vein Occlusions
Intervention:
2 Completed
Has Results
A Study of a Sustained Release Fluocinolone Implant for Treatment of Central Retinal Vein Occlusion
Condition: Central Retinal Vein Occlusion
Intervention: Device: fluocinolone acetonide (Retisert Implant, Bausch and Lomb)
3 Completed Retinal Vessel Diameter in Branch Retinal Vein Occlusion
Condition: Branch Retinal Vein Occlusion
Intervention:
4 Completed Fluocinolone Acetonide Implant for Retinal Vein Occlusion (RVO)
Condition: Retinal Vein Occlusion
Intervention: Device: fluocinolone acetonide (Retisert Implant)
5 Active, not recruiting Continuing Assessment of Patients Treated With ranibizUmab for REtinal Vein Occlusion (CAPTURE)
Condition: Retinal Vein Occlusion
Intervention:
6 Completed Sheathotomy vs. Intravitreal Triamcinolone for Branch Retinal Vein Occlusion
Conditions: Macular Edema;   Branch Retinal Vein Occlusion
Interventions: Procedure: Arteriovenous Crossing Sheathotomy;   Procedure: Intravitreal Triamcinolone Acetonide Injection
7 Completed
Has Results
Ranibizumab DosE Comparison and the Role of LAser in REtinal Vein Occlusions
Condition: Retinal Vein Occlusion
Interventions: Drug: Ranibizumab 0.5mg (monthly);   Drug: Ranibizumab 2.0mg (monthly);   Drug: Pro re nata (prn) ranibizumab;   Procedure: Pro re nata (prn) Laser photocoagulation
8 Completed Ranibizumab in Patients With Branch Retinal Vein Occlusion
Condition: Retinal Vein Occlusion
Intervention: Drug: Lucentis
9 Terminated Radial Optic Neurotomy in Central Retinal Vein Occlusion : a Randomized Trial
Condition: Retinal Vein Occlusion
Intervention: Procedure: vitrectomy with radial optic neurotomy
10 Completed
Has Results
Efficacy and Safety of Ranibizumab With or Without Laser in Comparison to Laser in Branch Retinal Vein Occlusion
Condition: Branch Retinal Vein Occlusion
Interventions: Drug: Ranibizumab;   Procedure: Laser
11 Suspended Minocycline to Treat Central Retinal Vein Occlusion
Condition: Retinal Vein Occlusion
Intervention: Drug: Minocycline
12 Completed Lucentis for Macular Edema Associated With Central Retinal Vein Occlusion
Condition: Central Retinal Vein Occlusion
Intervention: Drug: Ranibizumab (Lucentis)
13 Suspended Minocycline to Treat Branch Retinal Vein Occlusion
Condition: Retinal Vein Occlusion
Intervention: Drug: Minocycline
14 Completed Retinal Ischemia in Central Retinal Vein Occlusion, and the Effects of Treatment With Intravitreal Ranibizumab
Condition: Central Retinal Vein Occlusion
Intervention:
15 Unknown  Retinal Blood Flow in Response to an Intravitreal Injection of Ranibizumab for Central Retinal Vein Occlusion (CRVO)
Condition: Central Retinal Vein Occlusion
Intervention:
16 Completed Diameters and Wall-to-lumen Ratio of Retinal Arterioles in Patients With Retinal Vein Occlusion.
Condition: Hypertensive Patients With Retinal Vein Occlusion
Intervention: Device: Dexamethasone Intravitreal Implant (Ozuredex)
17 Completed Exploratory Study of KPI-121 Effect on Intra- or Subretinal Fluid Due to Retinal Vein Occlusion/Diabetic Macular Edema
Conditions: Retinal Vein Occlusion;   Diabetic Macular Edema
Intervention: Drug: KPI-121
18 Unknown  Intra-arterial Thrombolysis for Severe Recent Central Retinal Vein Occlusion
Condition: Central Retinal Vein Occlusion
Intervention: Drug: Tissue Plasminogen Activator
19 Recruiting Comparing the Effectiveness and Costs of Bevacizumab to Ranibizumab in Patients With Retinal Vein Occlusions (BRVO)
Condition: Retinal Vein Occlusion
Interventions: Drug: Bevacizumab;   Drug: Ranibizumab
20 Unknown  Efficacy and Safety of Lucentis for Clinically Significant Macular Edema Secondary to Central Retinal Vein Occlusion
Conditions: Retinal Vein Occlusion;   Macular Edema
Interventions: Drug: ranibizumab;   Radiation: Argon laser treatment

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.